miR-133a-3p Regulates Hepatocellular Carcinoma Progression Through Targeting CORO1C

miR-133a-3p Regulates Hepatocellular Carcinoma Progression Through Targeting CORO1C

Shuangxi Han,1,2 Xuemei Ding,1 Shaohong Wang,1 Li Xu,1 Wenxiao Li,1 Wenbing Sun1 1Department of Hepatobiliary Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100043, People’s Republic of China; 2Department of Hepatobiliary Surgery, Binzhou Central Hospital, Binzhou...

Full description

Bibliographic Details
Main Authors:	Han S, Ding X, Wang S, Xu L, Li W, Sun W
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-09-01
Series:	Cancer Management and Research
Subjects:	mir-133a-3p coro1c hepatocellular carcinoma prognosis
Online Access:	https://www.dovepress.com/mir-133a-3p-regulates-hepatocellular-carcinoma-progression-through-tar-peer-reviewed-article-CMAR

Similar Items

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
by: Yao-Li Chen, et al.
Published: (2017-07-01)

Expressions of miR-96 and miR-103 in Hepatocellular Carcinoma and Their Correlation with Prognosis
by: XIAO Wei, et al.
Published: (2020-06-01)

Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
by: Abdel-Rahman N. Zekri, et al.
Published: (2017-03-01)

Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
by: He Wang, et al.
Published: (2021-06-01)

miR-133a function in the pathogenesis of dedifferentiated liposarcoma
by: Peter Y. Yu, et al.
Published: (2018-06-01)

The Changes Of Heart MiR-1 And MiR-133 Expressions Following Physiological Hypertrophy Due To Endurance Training
by: Mohammad Fathi, et al.
Published: (2020-09-01)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
by: Khalda S. Amr, et al.
Published: (2017-12-01)

Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion
by: Wu Zheng-sheng, et al.
Published: (2012-02-01)

Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease
by: Xiong Zhang, et al.
Published: (2017-06-01)

circPCNX and Pecanex Promote Hepatocellular Carcinoma Cell Viability by Inhibiting miR-506
by: Sun P, et al.
Published: (2020-01-01)

miR‐133a Replacement Attenuates Thoracic Aortic Aneurysm in Mice
by: Adam W. Akerman, et al.
Published: (2021-08-01)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Long J, et al.
Published: (2022-02-01)

High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
by: Li Y, et al.
Published: (2019-04-01)

IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells
by: Yafei Zhang, et al.
Published: (2013-01-01)

CORO6 Promotes Cell Growth and Invasion of Clear Cell Renal Cell Carcinoma via Activation of WNT Signaling
by: Xinjun Wang, et al.
Published: (2021-05-01)

MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
by: Yinghui Hong, et al.
Published: (2021-03-01)

MiR-133b Promotes Neurite Outgrowth by Targeting RhoA Expression
by: Xiao Cheng Lu, et al.
Published: (2015-01-01)

miR-451 Up-regulation, Induce Erythroid Differentiation of CD133+cells Independent of Cytokine Cocktails
by: Fatemeh Kouhkan, et al.
Published: (2013-06-01)

The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression
by: Sabrina Caporali, et al.
Published: (2021-09-01)

LncR-133a Suppresses Myoblast Differentiation by Sponging miR-133a-3p to Activate the FGFR1/ERK1/2 Signaling Pathway in Goats
by: Siyuan Zhan, et al.
Published: (2022-05-01)

Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial
by: Hanren Dai, et al.
Published: (2020-01-01)

Overexpression of HSP70 attenuates sarcopenia by suppressing the expression of miR‐133b
by: Tábata L. Nascimento, et al.
Published: (2020-07-01)

Obesity-induced inflammatory miR-133a mediates apoptosis of granulosa cells and causes abnormal folliculogenesis
by: Chen Ruizhi, et al.
Published: (2023-06-01)

Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction
by: Yajun Gui, et al.
Published: (2018-05-01)

Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
by: Nannan Zhang, et al.
Published: (2019-12-01)

LINC02381 Promoted Cell Viability and Migration via Targeting miR-133b in Cervical Cancer Cells
by: Chen X, et al.
Published: (2020-05-01)

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression
by: Zhongyuan Cui, et al.
Published: (2023-01-01)

Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats
by: Sen Yin, et al.
Published: (2019-11-01)

miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells
by: Lantang Huang, et al.
Published: (2022-11-01)

El coro en los fragmentos trágicos de Esquilo
by: Míriam Librán Moreno
Published: (2020-06-01)

The role of miR1 and miR133a in new-onset atrial fibrillation after acute myocardial infarction
by: Qingyi Zeng, et al.
Published: (2023-09-01)

LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c
by: Shuai Xue, et al.
Published: (2021-04-01)

Circulatory miR-133a and miR-145 are Associated with the Improving Impact of Combined Endurance Exercise and MitoQ on Cardiovascular Function in Patients with Hypertension
by: Yaser Masoumi-Ardakani, et al.
Published: (2024-03-01)

The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1
by: Zhu S, et al.
Published: (2021-07-01)

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01)

MiR-376a and Histone Deacetylation 9 Form A Regulatory Circuitry in Hepatocellular Carcinoma
by: Yongxia Zheng, et al.
Published: (2015-01-01)

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
by: Yang Zhou, et al.
Published: (2022-01-01)

The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma
by: Jiang P, et al.
Published: (2020-09-01)

miR-4270 suppresses hepatocellular carcinoma progression by inhibiting DNMT3A-mediated methylation of HGFAC promoter
by: Qiang Zou, et al.
Published: (2023-12-01)

A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population
by: Moqin Qiu, et al.
Published: (2020-10-01)